Caris Life Sciences Q3 EPS $0.05 Beats $0.04 Estimate, Sales $275.358M Beat $255.363M Estimate
Benzinga Newsdesk 7 hours ago
NewsEarningsEarnings Beats
Caris Life Sciences (NASDAQ:CAI) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.04 by 25 percent. This is a 37.5 percent decrease over earnings of $0.08 per share from the
Caris Life Sciences (NASDAQ:CAI) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.04 by 25 percent. This is a 37.5 percent decrease over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $275.358 million which beat the analyst consensus estimate of $255.363 million by 7.83 percent. This is a 26.99 percent increase over sales of $216.833 million the same period last year.